Auxilium Pharmaceuticals (AUXL) PT, Estimates Raised at Jefferies on Headcount Reduction
Tweet Send to a Friend
Jefferies analyst Thomas Wei raised estimates and his price target on Buy-rated Auxilium Pharmaceuticals (NASDAQ: AUXL) to $34.00 (from $32.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
